
STAT+: Roche expands its Boston footprint with new research center
A gene therapy approved for Sanfilippo syndrome, good and bad news for Xenon Pharma, and more biotech news
148 stories found

A gene therapy approved for Sanfilippo syndrome, good and bad news for Xenon Pharma, and more biotech news

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

The U.S. is working on rules for investing in China that would likely preserve pharma's ability to strike most licensing deals for Chinese drugs

Kennedy speaks at the Children's Health Defense, medical facilities under attack in Sudan, and more health news form Morning Rounds

James Deardorff, a geriatrician at UCSF, talks about the benefits and pitfalls of using AI to make care decisions for older adults.

Amid a civil war in Sudan, it’s now difficult for people with cancer and other long-term illnesses to receive treatment that was once readily available

“The young men in my clinic are responding rationally to a system that was designed for profit,” writes plastic surgeon Kavitha Ranganathan.

It wasn’t until he started medical school, Brian Zhang writes, that he realized ‘Asian glow’ from drinking was a sign of something important.

Health secretary Kennedy announced a new effort to improve autism diagnoses, arguing that the current model is outdated

Health secretary RFK Jr. returned to his roots in a keynote address at a conference hosted by the Children’s Health Defense, an anti-vaccine nonprofit he helped start.

The FDA approved a new gene therapy for Sanfilippo syndrome type A, an ultra-rare disease sometimes known as childhood Alzheimer’s.

Researchers have identified a very rare genetic variant that is associated with higher odds of lung cancer in "never smokers."

International researchers got a reprieve in the courts this week. What does that mean for U.S. medical research? Find out on this week's episode of "The Readout LOUD" podcast.

The influential panel hasn't met in more than a year, after Kennedy canceled its meeting.

A psychedelic-like drug for a Parkinson's symptom, mice with half-human brains, and more biotech news in the Readout newsletter.

FDA's hiring bottleneck, Dems plan for health care oversight, and more from STAT's D.C. Diagnosis newsletter.

Cautious optimism in the Ebola outbreak, FDA still stymied by DOGE cuts, and other health updates from the Morning Rounds newsletter.

Covered by The Guardian – Health, BBC News – Health, STAT News. Thousands with HER2-low advanced breast cancer will have access to Enhertu after ministers strike deal on price Thousands of women in England with incurable breast cancer will get access to a life-extending drug on the…

In this edition of STAT Health Tech: Zocdoc enables appointment scheduling from chatbots and health plan websites, and more.

For all the talk of a hiring spree at the FDA after DOGE cuts last year, the reality is more complicated and filled with bureaucratic delays